Recalcitrant Prurigo Nodularis Successfully Treated with Dupilumab

QR Code

Recalcitrant Prurigo Nodularis Successfully Treated with Dupilumab

Saved in:

Bibliographic Details
Main Authors:	Gopikrishnan Anjaneyan, Smruthi Reddy, Lydia Mathew, Vimi Ponnamparambath
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Indian Dermatology Online Journal
Online Access:	https://journals.lww.com/10.4103/idoj.idoj_446_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab
by: Zhang Y, et al.
Published: (2025-06-01)

Immunometabolic reprogramming in the management of prurigo nodularis with methotrexate
by: Viviane Liao, BA, et al.
Published: (2025-09-01)

Prurigo Nodularis at Ultra-High-Frequency Ultrasound
by: Alessandra Michelucci, et al.
Published: (2025-06-01)

Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature
by: Li B, et al.
Published: (2025-05-01)

Prurigo Nodularis in a Patient With Primary B‐Cell Immunodeficiency Successfully Treated With Low‐Dose Methotrexate: A Case Report
by: Hamad El Hajj, et al.
Published: (2025-07-01)

Clinical observation of a prurigo nodularis in a HIV-positive patient
by: E. N. Efanova, et al.
Published: (2021-12-01)

Estimating the healthcare burden of Prurigo Nodularis in England: a CPRD database study
by: Donia Bahloul, et al.
Published: (2024-12-01)

Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review
by: Boonpethkaew S, et al.
Published: (2025-07-01)

Recalcitrant seeds /
by: Chin, H. F.
Published: (1989)

Prurigo de Hebra
by: Marta Inés Arias Escobar, et al.
Published: (1995-07-01)

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin
by: Megan E. McNamara, PhD, et al.
Published: (2025-08-01)

Somatic Embryogenesis in Recalcitrant Plants
by: Solís-Ramos, Laura Yesenia, et al.
Published: (2012)

Successful treatment of scleromyxedema with dupilumab: A case report
by: Abdulelah Alghamdi, MBBS, et al.
Published: (2025-09-01)

TARGETED THERAPY IN THE TREATMENT OF NODULAR PRURIGO
by: Natalia Shestakova, et al.
Published: (2019-08-01)

Cutaneous IgG4-related disease treated with dupilumab
by: Mafalda Pestana, et al.
Published: (2025-04-01)

Application of Microwave Technology for Utilization of Recalcitrant Biomass
by: Tsubaki, Shuntaro, et al.
Published: (2011)

Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024-09-01)

Successful management of Netherton syndrome using IVIG and dupilumab: A case report
by: Reshale Johar, MD, et al.
Published: (2025-08-01)

Successful treatment of a case of dupilumab-induced psoriasis and alopecia areata with tofacitinib
by: SUN Feifei, et al.
Published: (2025-06-01)

Prurigo nodular tratado con UVB de banda estrecha
by: Diego Mauricio Ordóñez, et al.
Published: (2019-02-01)

Dupilumab Efficacy in Children with Palmoplantar Eczema
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Modern Possibilities of Usage Dupilumab in Children
by: Anna A. Kosova, et al.
Published: (2024-12-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

Metabolomic Profiling of Desiccation Response in Recalcitrant <i>Quercus acutissima</i> Seeds
by: Haiyan Chen, et al.
Published: (2025-07-01)

Acute generalized exanthematous pustulosis triggered by dupilumab
by: Caterina Mariarosaria Giorgio, et al.
Published: (2025-07-01)

Effective treatment of recalcitrant palmoplantar psoriasis in a patient with skin of color using bimekizumab
by: Emily G. Tocco, BS, et al.
Published: (2025-09-01)

Accessing Bisphosphine Copper(I) Complexes with Recalcitrant Pterin–Phenanthroline Ligands Through Mechanochemistry
by: Siva S. M. Bandaru, et al.
Published: (2025-05-01)

Prurigo nodular como manifestación paraneoplásica de un linfoma hodgkin de localización mediastinal
by: Miguel Emilio García Rodríguez, et al.
Published: (2024-10-01)

Alopecia Areata Associated with Dupilumab: National Database Study
by: Tarun Sontam, et al.
Published: (2025-07-01)

Dupilumab for management of capecitabine-induced hand-foot syndrome
by: Ian Nykaza, BS, et al.
Published: (2025-09-01)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023-03-01)

Antibiotic-recalcitrant Salmonella exploits post-antibiotic microbiota disruption to achieve virulence-dependent transmission
by: Joshua P.M. Newson, et al.
Published: (2025-07-01)

Competing Plant Cell Wall Digestion Recalcitrance by Using Fungal Substrate – Adapted Enzyme Cocktails
by: Phalip, Vincent, et al.
Published: (2012)

Letter to Editor: Oral Isotretinoin in Recalcitrant Facial Flat Warts—Methodological and Reporting Gaps Undermine Generalizability
by: Ruba Javed, et al.
Published: (2025-07-01)

Alternative Treatment of Recalcitrant Organic Contaminants by a Combination of Biosorption, Biological Oxidation and Advanced Oxidation Technologies
by: Candal, Roberto, et al.
Published: (2012)

The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024-02-01)

Achievement of Control of Severe Bronchial Asthma When Using Dupilumab
by: O. V. Kazmerchuk, et al.
Published: (2024-11-01)

Dupilumab for the treatment of COPD: protocol for a systematic review and meta-analysis
by: Bingyu Xue, et al.
Published: (2025-07-01)

Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis
by: Paulina Stepinska, et al.
Published: (2025-12-01)